Analysis Of Financial Performance Of Health-100's Backdoor Listing

In China,companies can become financing platforms through going public,and driven by this interest,more and more companies want qualified listing.However,in China,IPO listing is subject to the approval system,and domestic companies want to go public.This requires the China Securities Regulatory Commission to carry out strict and lengthy relevant approval procedures.However,after the IPO process is passed,companies at this time have often missed the most.Good timing for financing.In contrast,the time required for backdoor listing is shorter and the procedure is simpler.With the backdoor listing approach,not only the optimal allocation of resources can be achieved,but also private enterprises can help solve the problem of capital shortage,which is a fast way for capital.Expansion provides protection and promotes enterprise development.However,in real life,there are many cases in which companies have failed to backdoor listing.There are also backdoors that have been successful,but many problems have been exposed in later developments.Therefore,how to successfully “backdoor listing” allows enterprises to maintain their vitality in the subsequent development,which is a daunting challenge for the rapid development of private enterprises.In recent years,with the continuous advancement of policies such as medical insurance control fees,cancellation of drug additions,payment by case,"two-vote system",and the emergence of similar enterprises,the pharmaceutical industry is facing increasing competitive pressure..At present,China's private medical industry has a small and scattered status quo,the scale has become an inevitable trend in the development of the industry,has developed to the stage of the industry reshuffle through mergers and acquisitions to enhance industry concentration.This article also hopes to take advantage of the successful case of Health-100's backdoor listing.It elaborates on the process of Health-100's backdoor listing,and analyzes in depth the causes of Health-100's backdoor listing and related performance.This paper selects the case of Health-100's backdoor Sanyou listing as the research object.First of all,the literature research method is used to sort out relevant researches on backdoor listing of enterprises by domestic and foreign scholars,and to find the theoretical basis for the research.Secondly,the specific process of backdoor listing is analyzed,and the results of this backdoor event are analyzed through the event analysis method.Give evaluation;again,through the big data platform for information and data collection,and the use of financial indicators analysis,EVA trend analysis and other methods to analyze the impact of Health-100's backdoor listing on financial performance,and concluded that the relevant conclusions: Backdoor listing helps to increase Health-100's profitability and management level.Case selection reasons: First,Health-100 is a leading enterprise in the health examination industry.The success of the case study has a certain degree of representation.Second,Health-100 made a share purchase for the peer competitor Ci Ming during the preparation period for the backdoor.